RSS Feed
Poniard Finds Cash to Keep Lights On: BioBuzz
A failed drug test last week had put Poniard in a cash-crunch situation.
12:59PM 11/23/09
Cel-Sci Chairman Sells Stock, Despite Sweetheart Loan Deal: BioBuzz
Shareholders are on the hook for a generous loan repayment to Cel-Sci's founder.
10:14AM 11/23/09
FDA Issues New Obesity Drug Heart Warning: BioBuzz
Safety of Abbott's Meridia may heighten concerns for all weight-loss drugs
08:15AM 11/23/09
Biotech Stock Mailbag: FDA Playbook
Smart drug and biotech companies keep the FDA abreast of their clinical trial program throughout the long drug-development process.
06:01AM 11/20/09
U.S. Sees Low Demand for BioCryst Flu Drug
Peaking flu season could mean no need for further peramivir orders.
11:12AM 11/18/09
Another Genzyme Drug Goes Kaboom: BioBuzz
Company halts development of kidney disease drug following poor test results.
08:05AM 11/18/09
Vivus Seeks Faster ED Drug: Biobuzz
Company says ED drug met all goals in phase III study.
06:42AM 11/18/09
Genzyme's Termeer: Worst Biotech CEO of '09
Genzyme CEO Henri Termeer is Adam Feuerstein's Worst Biotech CEO of the Year for 2009.
12:31PM 11/17/09
InterMune Hep C Drug Hit With Liver Tox Worry: BioBuzz
Safety monitors force change to mid-stage study of ITMN-191
09:11AM 11/17/09
Poniard's CEO Pulls a Belichik: BioBuzz
Risky late-game call puts Poniard in a deep financial hole.
11:59AM 11/16/09
Connect with TheStreet